These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 24144459)

  • 1. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry.
    Delisle VC; Hudson M; Baron M; Thombs BD; And The Canadian Scleroderma Research Group A
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-10-4. PubMed ID: 24144459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to diagnosis in systemic sclerosis: is sex a factor?
    Hudson M; Thombs B; Baron M;
    Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
    Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study.
    Virgili-Gervais G; Matthews B; Nassar EL; Carrier ME; Kwakkenbos L; Pauling JD; Bartlett SJ; Gietzen A; Gottesman K; Guillot G; Hudson M; Hummers LK; Lawrie-Jones A; Malcarne VL; Mayes MD; Richard M; Sauvé M; Wojeck RK; Mouthon L; Benedetti A; Thombs BD;
    Lancet Rheumatol; 2024 Oct; 6(10):e684-e692. PubMed ID: 39216493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients.
    Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Clin Rheumatol; 2011 Sep; 30(9):1235-40. PubMed ID: 21484224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
    Hong P; Pope JE; Ouimet JM; Rullan E; Seibold JR
    J Rheumatol; 2004 Mar; 31(3):508-13. PubMed ID: 14994396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac involvement at rest in patients with systemic sclerosis: differences between the limited and the diffuse form of the disease].
    Faccini A; Franchini S; Sabbadini MG; Camici PG
    G Ital Cardiol (Rome); 2014 Jan; 15(1):44-50. PubMed ID: 24503734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement.
    Christopoulos PF; Bournia VK; Panopoulos S; Vaiopoulos A; Koutsilieris M; Sfikakis PP
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S36-9. PubMed ID: 26121083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and impact of disease symptoms experienced by patients with systemic sclerosis from five European countries.
    Willems LM; Kwakkenbos L; Leite CC; Thombs BD; van den Hoogen FH; Maia AC; Vliet Vlieland TP; van den Ende CH
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-88-93. PubMed ID: 25372793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
    Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification criteria of scleroderma].
    Cabane J;
    Presse Med; 2006 Dec; 35(12 Pt 2):1916-22. PubMed ID: 17159717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse scleroderma and Raynaud's disease.
    JABLONSKA S; BUBNOW B; SZCZEPANSKI A
    Br J Dermatol; 1962 May; 74():174-82. PubMed ID: 14450537
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.
    Carreira PE; Carmona L; Joven BE; Loza E; Andréu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker U; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y
    Scand J Rheumatol; 2019 Jan; 48(1):42-51. PubMed ID: 30039730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.